ArticleNature cancer2025

Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability.

Jenna M Whalen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.